A. Somfay (Szeged, Hungary), S. Loukides (Athens, Greece)
Features of non-obstructive emphysema in a population who underwent chronic disease screening
J. H. Park, Y. J. Jung, W. Y. Jung, K. S. Lee, S. S. Sheen, K. J. Park, S. C. Hwang (Suwon, Republic Of Korea)
|   |
The British Lung Foundation‘s UK crusade to find undiagnosed COPD
I. Jarrold, T. Lethbridge, K. Leach, M. McConnochie, J. Taylor, N. Eiser (London, United Kingdom)
| |
Lack of sex difference in lung function decline in emphysema
H. Ward, M. Miller, R. Stockley (United Kingdom)
| |
Evaluation of the differences of small airways impairment between chronic obstructive disease (COPD) and bronchiolitis obliterans syndrome (BOS) by using impulse oscillometory
J. Kitada, H. Tanaka, M. Fujii, H. Yasui, T. Hayashi, T. Ishida, Y. Sinomura, H. Takahashi (Japan)
| |
Physiologic study of patients with COPD: Respiratory mechanics according to staging of GOLD and BODE index
Z. Karakurt, S. Nava, A. Carlucci, F. Fanfulla, P. Ceriana, S. Karakurt, S. Cirio (Istanbul, Turkey; Pavia, Italy)
| |
Pathophysiological notions on the evolution of peripheral airways disease (PAD) to overt COPD
S. A. Gennimata, A. Palamidas, G. Kaltsakas, F. Karakontaki, E. Kosmas, A. Koutsoukou, S. Loukides, N. Koulouris (Attica, Greece)
| |
Severity of COPD is associated with leg atherosclerosis
K. Fukumitsu, H. Matsuoka, M. Deguchi, T. Ryoke, Y. Koma, Y. Kasai, D. Masuya, H. Yoshimatsu, Y. Suzuki (Kobe, Japan)
| |
Comorbidities in patients with COPD: Associations with clinically relevant parameters
K. Kontogianni, A. Papaioannou, P. Bakakos, K. Gourgoulianis, S. Papiris, K. Kostikas, S. Loukides (Athens, Larissa, Greece)
| |
Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype?
M. Minas, A. Papaioannou, P. Mystridou, E. Karetsi, P. Georgoulias, N. Liakos, S. Pournaras, K. Gourgoulianis, K. Kostikas (Larissa, Greece)
| |
Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency
R. Carter, A. Dirksen, E. Piitulainen, R. Stockley (United Kingdom; Hellerup, Denmark; Malmö, Sweden)
| |
Earlier onset of fatigue in bronchiectasis as compared to COPD?
J. Macfarlane, H. Tedd, T. Small, J. Newton, A. De Soyza (Newcastle upon Tyne, United Kingdom)
| |
Physical performance, nutritional status, and fat-free mass in older COPD patients
D. Chiurco, C. Pedone, S. Scarlata, M. Cesari, I. Caridi, M. E. Conte, R. Antonelli Incalzi (Rome, Italy)
| |
Volumetric CT emphysema quantification for predicting pulmonary hypertension in patients with moderate to severe stable COPD
S. W. Park, J. S. Park, A. S. Jang, D. J. Kim, J. H. Lee, J. S. Park, C. S. Park (Republic Of Korea)
| |
Pulmonary hypertension is a common complication of COPD, but CT scanning and lung function tests do not identify patients at risk
A. M. Higton, C. A. Benjamin-Smith, E. C. Floyd, R. G. Harvey, E. H. Baker (London, United Kingdom)
| |
Evaluation of retrobulbar arterial blood flow changes in chronic obstructive pulmonary disease by color Doppler ultrasonography
H. Makhlouf, H. Mohammadien, H. Abdelmotaal, H. Yousef (Assuit, Egypt)
| |
Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction
W. Mazur, T. Toljamo, P. Nieminen, S. Ohlmeier, H. Kobayashi, V. Kinnula (Rovaniemi, Oulu, Finland; Tokorozawa, Japan)
| |
Plasma acrolein level and myeloperoxidase gene polymorphism in COPD
M. Ito, M. Hanaoka, Y. Droma, N. Kobayashi, Y. Kitaguchi, Y. Katsuyama, M. Ota, K. Kubo (Matsumoto, Japan)
| |
The effect of smoking and COPD on exhaled breath temperature
S. Kløkstad, A. Bikov, Z. Lazar, G. Galffy, G. Losonczy, I. Horvath (Budapest, Hungary)
| |
Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease
S. Eker, L. Ayaz, L. Tamer, B. Ulubas (Mersin, Turkey)
| |
Alpha-1 antitrypsin COPD phenotypes are clinically more valid when defined by LLN rather than percent of predicted
H. Ward, M. Miller, R. Stockley (United Kingdom)
| |